Skip Navigation HRSA - U.S Department of Health and Human Services, Health Resources and Service Administration HHS
Home
Questions
Order Publications
 
Grants Find Help Service Delivery Data Health Care Concerns About HRSA

Pharmacy Affairs & 340B Drug Pricing Program



Final Notice Regarding the 340B Drug Pricing Program; Children’s Hospitals has been published. HRSA will strive to be as flexible as possible with application deadlines and will work with eligible children's hospitals to expedite registration as much as resources and program requirements permit.

Congratulations to Children's Hospital of Michigan as the first Children's Hospital in the 340B Program!!


Webinar: The Office of Pharmacy Affairs (OPA) hosted several webinars in September that were recorded and available for viewing. 

The children’s hospitals webinars: Exit Disclaimer  September 3, 2009 & September 9, 2009

The OPA Overview:Exit Disclaimer  September 28, 2009
(USER ID:  PW9204773  PSWD: LEADER)


Due to the Federal Public Health Emergency Declaration created because of the H1N1 flu outbreak which remains a worldwide public health threat, the Office of Pharmacy Affairs (OPA) is:

  • Initiating an emergency response and accepting requests for rolling registrations on a case by case basis.
  • If the requests are approved, OPA will accelerate the start dates for new sites so they may immediately begin participation in the 340B Program.

A component of the Health Resources and Services Administration Healthcare Systems Bureau, the Office of Pharmacy Affairs has three primary functions:

  • Administration of the 340B Drug Pricing Program, through which certain federally funded grantees and other safety net health care providers may purchase prescription medication at significantly reduced prices.
  • Development of innovative pharmacy services models and technical assistance.
  • Service as a federal resource about pharmacy.

In all of its activities, OPA emphasizes the importance of comprehensive pharmacy services being an integral part of primary health care.  Comprehensive pharmacy services include patient access to affordable pharmaceuticals, application of "best practices" and efficient pharmacy management and the application of systems that improve patient outcomes through safe and effective medication use.

Office of Pharmacy Affairs
5600 Fishers Lane,
Parklawn Building, Mail Stop 10C-03
Rockville, MD 20857


Current Issues Highlights
 

PVP Catalog available from the 340B Prime Vendor Apexus® (XLS - 759 KB) Exit Disclaimer (November 19, 2009)

Fresenius’ Letter to OPA regarding sales of Venofer®
(November 17, 2009)

H1N1 Guidance for HRSA Grantees (September 15, 2009)

Issues Concerning Certain Disproportionate Share Hospitals Continued Participation in the 340B Program (PDF - 16 KB) (August 28, 2009)

Amgen's Letter to OPA - pricing adjustments to PHS Pricing for three Vectibix® NDC Products (August 6, 2009)

340B Drug Pricing Program Flexibilities During Emergencies and Disaster (May 1, 2009)

HRSA issues Medicaid Exclusion Tutorial and Medicaid Exclusion File Basics - March 2008

HRSA Patient Safety & Clinical Pharmacy Services Collaborative February 2008

More Current Issues